Published in Contracept Fertil Sex on September 01, 1995
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation (1994) 12.24
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 2.70
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J (2004) 2.18
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 2.06
The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol (1998) 2.04
Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet (1999) 1.95
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry (2012) 1.84
Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr (1998) 1.74
Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry (2008) 1.71
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
Association of occurrence of aneurysmal bleeding with meteorologic variations in the north of France. Stroke (1994) 1.65
Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology (2007) 1.64
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry (2011) 1.59
The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J (2002) 1.58
Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology (2011) 1.57
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet (1998) 1.53
Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord (2001) 1.53
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation (2004) 1.52
Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2005) 1.52
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology (2005) 1.50
Sex differences in awareness and control of hypertension in France. J Hypertens (1997) 1.49
Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. Eur Heart J (2000) 1.45
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb (1992) 1.45
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet (1997) 1.27
Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord (2000) 1.25
Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol (2004) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.20
Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet (2000) 1.18
Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol (1998) 1.17
A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet (1998) 1.17
The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet (2000) 1.16
A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.14
Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lancet (2001) 1.14
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology (2002) 1.14
Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology (1994) 1.12
Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol (1999) 1.09
Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum Mol Genet (1997) 1.08
Different alcohol drinking and blood pressure relationships in France and Northern Ireland: The PRIME Study. Hypertension (2001) 1.08
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur J Hum Genet (2004) 1.07
The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol (1997) 1.07
Testing for association between disease and linked marker loci: a log-linear-model analysis. Am J Hum Genet (1991) 1.05
Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 1.01
Resting heart rate, mortality and future coronary heart disease in the elderly: the 3C Study. Eur J Cardiovasc Prev Rehabil (2011) 1.01
Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease? J Neurol Neurosurg Psychiatry (2005) 1.01
Incidence, case fatality, risk factors of acute coronary heart disease and occupational categories in men aged 30-59 in France. Int J Epidemiol (1997) 1.01
Psychosocial risk factors for heart disease in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Int J Epidemiol (2002) 1.01
Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb (1994) 1.01
Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study. J Neurol Neurosurg Psychiatry (2002) 1.01
Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology (2000) 1.01
Association between nutrition knowledge and nutritional intake in middle-aged men from Northern France. Public Health Nutr (2001) 0.99
The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab (2003) 0.98
Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord (2000) 0.96
ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neurosci Lett (1995) 0.96
Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AML. Leukemia (2007) 0.96
APOE genotyping and response to drug treatment in Alzheimer's disease. Lancet (1997) 0.95
Depressed mood and dietary fish intake: direct relationship or indirect relationship as a result of diet and lifestyle? J Affect Disord (2007) 0.95
Sedentary behaviour, physical activity and dietary patterns are independently associated with the metabolic syndrome. Diabetes Metab (2012) 0.95
Influence of parental history of hypertension on blood pressure. J Hum Hypertens (1999) 0.95
Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study. J Hum Hypertens (2010) 0.95
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost (1998) 0.94
Impact of REV-ERB alpha gene polymorphisms on obesity phenotypes in adult and adolescent samples. Int J Obes (Lond) (2012) 0.94
No pathogenic mutations in the beta-synuclein gene in Parkinson's disease. Neurosci Lett (1999) 0.94
Induction of proliferation of neuroretina cells by long terminal repeat activation of the carboxy-terminal part of c-mil. Mol Cell Biol (1987) 0.94
Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms. Neurobiol Aging (2001) 0.93
Change in cardiovascular risk factors in France, 1985-1997. Eur J Epidemiol (2004) 0.92
Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol (1997) 0.91
Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations. Int J Obes (Lond) (2008) 0.91
The North-East-South gradient of coronary heart disease mortality and case fatality rates in France is consistent with a similar gradient in risk factor clusters. Eur J Epidemiol (2000) 0.91
Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci Lett (1994) 0.91
Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study. Heart (2009) 0.91
Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease. Mol Psychiatry (2004) 0.90
Cognitive decline and survival in Alzheimer's disease according to education level. Dement Geriatr Cogn Disord (2007) 0.90
Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J (1999) 0.90
Morphology, homogeneity and functionality of human monocytes-derived macrophages. Cell Mol Biol (Noisy-le-grand) (2003) 0.89
Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France. Atherosclerosis (2000) 0.89
Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease. Hum Genet (1999) 0.89
Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet (2003) 0.89
Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study. Int J Obes (Lond) (2009) 0.88
Influence of alcohol consumption and various beverages on waist girth and waist-to-hip ratio in a sample of French men and women. Int J Obes Relat Metab Disord (1998) 0.88
[Epidemiology of sudden coronary death in France (1985-1982)]. Arch Mal Coeur Vaiss (1997) 0.88
Heart tumors specifically induced in young avian embryos by the v-myc oncogene. Proc Natl Acad Sci U S A (1987) 0.88
Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health (2002) 0.88
An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort. Diabetologia (2000) 0.87
Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel. Neurosci Lett (1996) 0.86
Is hospital care involved in inequalities in coronary heart disease mortality? Results from the French WHO-MONICA Project in men aged 30-64. J Epidemiol Community Health (1998) 0.86